Transcripts
Alnylam Pharmaceuticals (ALNY) earnings call transcripts
Earnings call transcripts for Alnylam Pharmaceuticals, Inc., with a summary, the guidance given, and what analysts pressed on.
- Q2 2026 earnings call
Management framed the call around a strong launch and durable TTR opportunity, while acknowledging its original 2026 demand assumptions were too optimistic.
Jul 30, 2026Positive0.55